DBV:FRA
DBV Technologies SA
€2.31
arrow_upward
+0.17%(+0.0040) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
€2.31
High
€2.31
Low
€2.31
Mkt. cap
771.11M
Avg. vol.
129.00
Volume
0.00
52-wk high
€4.75
52-wk low
€1.41
EPS
-€0.62
No. of employees
170
Open
€2.31
High
€2.31
Low
€2.31
Mkt. cap
771.11M
Avg. vol.
129.00
Volume
0.00
52-wk high
€4.75
52-wk low
€1.41
EPS
-€0.62
No. of employees
170
News stories
From web sources and news partners
markets.businessinsider.com
·
1 day ago
DBV Technologies to Participate in Upcoming September Investor Conferences
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA